A previously unknown
5'nucleotidase (5'-
ribonucleotide phosphohydrolase, EC 3.1.3.5) (5'-Nase) specific for
orotidine 5'-monophosphate (OMP) hs been discovered. This
enzyme orotidine 5'-monophosphate phosphohydrolase (
OMPase), was isolated from mouse liver microsomes as a separate entity from the nonspecific 5'-Nase.
OMPase was partially purified and is shown to cleave OMP to
orotidine and
inorganic phosphate. The
enzyme has negligible activity towards
UMP,
CMP,
dTMP,
AMP,
IMP, GMP,
XMP,
6-azauridine 5'-monophosphate, 1-beta-D-ribofuranosylbarbituric
acid 5'-monophosphate (BMF), 2'-UMP, 3'-UMP,
2'-AMP, 3'-AMP,
ribose 5-phosphate and
beta-glycerophosphate, all of which--with the exception of the 2' or 3' monophosphates,
ribose 5'-phosphate, and
beta-glycerophosphate--are substrates for 5'-Nase. Both
enzymes are inhibited by NaF, but only
OMPase is inhibited by SF
reagents.
OMPase is not inhibited by
orotidine, orotate, BMP,
concanavalin A, or
tetramisole (an
alkaline phosphatase inhibitor).
OMPase had a Mr 53,000, Km value of 1 mM for OMP, and Vmax value of 49 nmol/min . mg of
protein at the present stage of purification.
OMPase activity has also been detected in various mammalian tissues including normal human tissues, human
tumor xenografts, lymphocytes, and rat liver.
OMPase may be responsible, in part, for the low levels of intracellular "free" OMP and for
orotidine accumulation in cells treated with
6-azauridine and patients suffering from aortic aciduria.